Profile: CardioDynamics focuses on fundamentally changing drug management with impedance cardiography (ICG). BioZ® is our primary product. It uses proprietary ICG technology to noninvasively assess a patient's hemodynamics, data that typically has been unavailable in the physician's office, and available on a limited basis in the hospital only through a time-consuming, costly, and potentially dangerous invasive procedure called pulmonary artery catheterization (PAC), or the swan ganz catheter. Our BioZ ICG monitoring is noninvasive, and can be performed in outpatient areas such as physician offices to obtain hemodynamic information for treating heart failure & high blood pressure, and optimizing pacemaker function.
The company was founded in 1980, has revenues of USD 10-25 Million, has ~150 employees and is ISO 9001, CE certified. NASDAQ:CDIC (SEC Filings)
9 Products/Services (Click for related suppliers)
|
| • Cardiac Hemodynamic Monitoring System for Cathlab |
| • Cardiac Monitoring |
| • Digital Impedance Signal Quantifier |
| • Electrocardiograph (FDA Code: DPS / 870.2340) An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart. |
| • Hemodynamic Monitoring Devices |
| • Hemodynamic Monitoring System |
| • Hemodynamic Monitors |
| • Impedance Cardiography System |
| • Impedance Plethysmograph (FDA Code: DSB / 870.2770) An impedance plethysmograph is a device used to estimate peripheral blood flow by measuring electrical impedance changes in a region of the body such as the arms and legs. |